Chemclin Diagnostics Co., Ltd.

¥5.77As of Sun 8 Nov 2026, 12:00 UTC
SSE:688468Healthcare
Country China
PE (Fwd) •••
TSR 6Y CAGR (23.37%)
Div yield —
ROE 2.01%
Diagnostics & Research
Beta (5Y) 0.21
PE TTM 74.41
TSR TTM (27.97%)
Mkt cap ¥2.277B
ROIC 0.98%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥7.39
28.05%
(58.93%)
Hold 11|3|10|2|5
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.07
0.07
0.07
0.07
27.95%
26.44%
16.85%
9.25%
Revenue¥M
196.2
192.3
193.7
190.8
7.98%
6.27%
4.03%
(0.32%)
Peers (US$341.3M)
Cap (US$)
PE
500.8M
—
404.9M
94.58x
252.1M
77.04x
400.5M
13.58x
Capital
TTM
5Y
10Y
Leveragex
1.059
(0.076)
(0.071)
EBIT/Intx
0.381
0.239
0.222
Own earn%
19.93
(61.17)
(48.38)
Sh yield%
37.40
31.79
30.98
Owners
Insiders/Inst%
6.32
56.66
Short interest%
3.57
SBC / revenue%
4.05
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
5–9
$1 testx
—
Incr. ROIC%
5